ZEB2 and non-small cell lung carcinoma: ZEB1 and ZEB2, and E-Cadherin inhibitors have been demonstrated to be negatively regulated by several miRNAs, including miR-101 in ovarian carcinoma [69], miR-139-5p in glioblastoma multiforme [70], miR-215 in NSCLC [71] and miR-132 in CRC and NSCLC [72,73].